Thus, it is important to assess TMPRSS2 expression in normal and cancer tissues, particular in prostate cancer tissues, for help in predicting the cancer patients’ susceptibility to SARS‐CoV‐2 infection and the disease outcome. This evidence concerns the gene TMPRSS2 and prostate carcinoma.